Deciphera Pharmaceuticals Inc.

01/24/2022 | Press release | Distributed by Public on 01/24/2022 16:06

Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session - Form 8-K